Generex Biotechnology Announces Investor Conference Call Scheduled for February 26, 2019
January 29, 2019 09:00 ET
|
Generex Biotechnology Corp.
Management to Provide Details on NuGenerex Immuno-Oncology: Dividend, New Acquisitions, IP Licensing Opportunities, and Strategic Plans for Public Listing Acquisition, Integration of Fuse...